SAM
STOK icon

Simplify Asset Management’s Stoke Therapeutics STOK Stock Holding History

Simplify Asset Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-102,985
Closed -$406K – 141
2023
Q3 		$406K Sell
102,985
-19,811
-16% -$130K 0.05% 105
2023
Q2 		$1.31M Hold
122,796
– – 0.17% 70
2023
Q1 		$1.02M Buy
+122,796
New +$1.11M 0.15% 62

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplify Asset Management's STOK Position: Q4 2023 in Review

Simplify Asset Management sold out of Stoke Therapeutics (STOK) in Q4 2023, closing a stake of 102,985 shares — an estimated $406K sold.

Simplify Asset Management first reported a position in STOK in Q1 2023 and held it in 3 quarters. The position peaked at $1.31M in Q2 2023. 81 funds tracked by Wall St. Rank hold STOK as of Q4 2023.

  • Simplify Asset Management reported no remaining Stoke Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplify Asset Management sold 102,985 Stoke Therapeutics shares in Q4 2023, an estimated $406K.
  • Simplify Asset Management first reported a position in Stoke Therapeutics in Q1 2023 and held it in 3 quarters.
  • Simplify Asset Management's Stoke Therapeutics position peaked at $1.31M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2023.

Based on Simplify Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.